Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival

The American Journal of the Medical Sciences(2023)10.1016/j.amjms.2023.03.003Source: DataRank Database

Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival is a research paper published in The American Journal of the Medical Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.82)OA: hybridTopics (32)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Joshua J. Solomon ORCID,Stephen M. Humphries ORCID,Jeffrey J. Swigris ORCID,Faduma Ahmed,Hong Wang ORCID

Live enrichment

PubMed:36918112 PMC:PMC10247162 OpenAlex:https://openalex.org/W4323975463

National Institutes of Health

Grant: AR066712

National Institutes of Health

Grant: AR07534

NIAMS NIH HHS

Grant: K23 AR066712

NIAMS NIH HHS

Grant: T32 AR007534

FWCI

0.82

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.amjmedsci.org/article/S0002962923010625/pdf

publisherhttp://www.amjmedsci.org/article/S0002962923010625/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0002962923010625?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0002962923010625?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.amjms.2023.03.003

Fields of Study

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisRheumatoid Arthritis Research and TherapiesSystemic Sclerosis and Related DiseasesHumansLung Diseases, InterstitialArthritis, RheumatoidIdiopathic Pulmonary FibrosisProtein-Arginine Deiminase Type 4Autoantibodies

MeSH Terms

Protein-Arginine Deiminase Type 4Arthritis, RheumatoidAutoantibodiesHumansLung Diseases, InterstitialIdiopathic Pulmonary Fibrosis

Keywords

MedicineInterstitial lung diseaseRheumatoid arthritisUsual interstitial pneumoniaLungIdiopathic pulmonary fibrosisAntibodyPneumoniaImmunologyPulmonary fibrosisArthritisDiseasePathologyInternal medicinePad4IpfIld

Sustainable Development Goals

SDG 0: Good health and well-being